Calvet X - Search Results

1

[Use of intravenous iron infusion in a gastroenterology day hospital: Indications, dosage and adverse effects].

Dosal A, Calvet X, Moreno L, López M, Figuerola A, Ruíz MA, Suárez D, Gené E, Miquel M, Villoria A. Dosal A, et al. Among authors: calvet x. Gastroenterol Hepatol. 2010 Aug-Sep;33(7):479-83. doi: 10.1016/j.gastrohep.2010.02.011. Gastroenterol Hepatol. 2010. PMID: 20435381 Spanish.

2

[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection].

Comet R, Calvet X, Navarro M, García N, Sanfeliu I. Comet R, et al. Among authors: calvet x. Gastroenterol Hepatol. 1998 Feb;21(2):81-3. Gastroenterol Hepatol. 1998. PMID: 9549183 Spanish.

3

Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers--a cost-effectiveness analysis.

Gené E, Calvet X, Azagra R. Gené E, et al. Among authors: calvet x. Aliment Pharmacol Ther. 2000 Apr;14(4):433-42. doi: 10.1046/j.1365-2036.2000.00735.x. Aliment Pharmacol Ther. 2000. PMID: 10759623

4

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

Calvet X, García N, López T, Gisbert JP, Gené E, Roque M. Calvet X, et al. Aliment Pharmacol Ther. 2000 May;14(5):603-9. doi: 10.1046/j.1365-2036.2000.00744.x. Aliment Pharmacol Ther. 2000. PMID: 10792124

5

Validation of phone interview for follow-up in clinical trials on dyspepsia: evaluation of the Glasgow Dyspepsia Severity Score and a Likert-scale symptoms test.

Calvet X, Bustamante E, Montserrat A, Roqué M, Campo R, Gené E, Brullet E. Calvet X, et al. Eur J Gastroenterol Hepatol. 2000 Aug;12(8):949-53. doi: 10.1097/00042737-200012080-00016. Eur J Gastroenterol Hepatol. 2000. PMID: 10958224

6

Limited usefulness of a seven-day twice-a-day quadruple therapy.

Garcia N, Calvet X, Gené E, Campo R, Brullet E. Garcia N, et al. Among authors: calvet x. Eur J Gastroenterol Hepatol. 2000 Dec;12(12):1315-8. doi: 10.1097/00042737-200012120-00008. Eur J Gastroenterol Hepatol. 2000. PMID: 11192320 Clinical Trial.

7

Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment.

Calvet X, Garcia N, Gené E, Campo R, Brullet E, Sanfeliu I. Calvet X, et al. Aliment Pharmacol Ther. 2001 Jul;15(7):1061-5. doi: 10.1046/j.1365-2036.2001.00984.x. Aliment Pharmacol Ther. 2001. PMID: 11421883 Clinical Trial.

8

What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis.

Calvet X, Gené E, López T, Gisbert JP. Calvet X, et al. Aliment Pharmacol Ther. 2001 Jul;15(7):1067-76. doi: 10.1046/j.1365-2036.2001.01031.x. Aliment Pharmacol Ther. 2001. PMID: 11421884

9

[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].

Gené E, Calvet X, Azagra R, López T, Cubells MJ. Gené E, et al. Among authors: calvet x. Aten Primaria. 2002 May 15;29(8):486-94. doi: 10.1016/s0212-6567(02)70618-5. Aten Primaria. 2002. PMID: 12031222 Free PMC article. Spanish.

10

Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy.

Calvet X, Gené E. Calvet X, et al. Helicobacter. 2002 Jun;7(3):216; author reply 216-7. doi: 10.1046/j.1523-5378.2002.00084_1.x. Helicobacter. 2002. PMID: 12047329 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters